HLA-C and neoplasm: Endogenously, the interplay between major histocompatibility complex (MHC)-displayed peptides and their T-cell receptor (TCR) triggers T-cells (5); nevertheless, the activation of CAR T-cells is contingent upon the presence of tumor-associated or tumor-specific antigens (TAA and TSA), respectively.